These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31183390)
21. The Influence of Zacarias JMV; de Alencar JB; Tsuneto PY; de Souza VH; Silva CO; Visentainer JEL; Sell AM Mediators Inflamm; 2019; 2019():4029217. PubMed ID: 31281226 [TBL] [Abstract][Full Text] [Related]
22. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585 [TBL] [Abstract][Full Text] [Related]
23. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654 [TBL] [Abstract][Full Text] [Related]
24. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis. Baltacıoğlu E; Kehribar MA; Yuva P; Alver A; Atagün OS; Karabulut E; Akalın FA J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481 [TBL] [Abstract][Full Text] [Related]
25. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242 [TBL] [Abstract][Full Text] [Related]
26. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325 [TBL] [Abstract][Full Text] [Related]
27. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. Menezes R; Garlet TP; Letra A; Bramante CM; Campanelli AP; Figueira Rde C; Sogayar MC; Granjeiro JM; Garlet GP J Endod; 2008 Aug; 34(8):932-8. PubMed ID: 18634923 [TBL] [Abstract][Full Text] [Related]
28. Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease. Cutando A; López-Valverde A; de Diego RG; de Vicente J; Reiter R; Fernández MH; Ferrera MJ Odontology; 2014 Jul; 102(2):290-6. PubMed ID: 23934086 [TBL] [Abstract][Full Text] [Related]
29. Leptin regulates OPG and RANKL expression in Gingival Fibroblasts and Tissues of Chronic Periodontitis Patients. Guo Y; Xu C; Wu X; Zhang W; Sun Y; Shrestha A Int J Med Sci; 2021; 18(11):2431-2437. PubMed ID: 33967621 [No Abstract] [Full Text] [Related]
30. Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. Bostanci N; Saygan B; Emingil G; Atilla G; Belibasakis GN J Clin Periodontol; 2011 May; 38(5):428-33. PubMed ID: 21261673 [TBL] [Abstract][Full Text] [Related]
31. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Liu D; Xu JK; Figliomeni L; Huang L; Pavlos NJ; Rogers M; Tan A; Price P; Zheng MH Int J Mol Med; 2003 Jan; 11(1):17-21. PubMed ID: 12469211 [TBL] [Abstract][Full Text] [Related]
32. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. Tobón-Arroyave SI; Isaza-Guzmán DM; Restrepo-Cadavid EM; Zapata-Molina SM; Martínez-Pabón MC J Clin Periodontol; 2012 Dec; 39(12):1132-40. PubMed ID: 23039038 [TBL] [Abstract][Full Text] [Related]
33. Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis. Behfarnia P; Saied-Moallemi Z; Javanmard SH; Naseri R Adv Biomed Res; 2016; 5():80. PubMed ID: 27195253 [TBL] [Abstract][Full Text] [Related]
34. [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. Zhao NN; Lin JX; Chen ZB; Liu Y Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):108-12. PubMed ID: 22353912 [TBL] [Abstract][Full Text] [Related]
35. Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid. Sarlati F; Sattari M; Razzaghi S; Nasiri M Dent Res J (Isfahan); 2012 Nov; 9(6):752-7. PubMed ID: 23559954 [TBL] [Abstract][Full Text] [Related]
36. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730 [TBL] [Abstract][Full Text] [Related]
38. Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio. Yan K; Lin Q; Tang K; Liu S; Du Y; Yu X; Li S BMC Oral Health; 2020 Jan; 20(1):27. PubMed ID: 32000757 [TBL] [Abstract][Full Text] [Related]
39. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492 [TBL] [Abstract][Full Text] [Related]
40. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]